Simplex Trading
RLAY icon

Simplex Trading’s Relay Therapeutics RLAY Stock Holding History

Simplex Trading’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,984
Closed -$11.4K – 9902
2025
Q2 		$10K Sell
2,984
-9,537
-76% -$28.4K ﹤0.01% 7334
2025
Q1 		$32K Sell
12,521
-34,941
-74% -$137K ﹤0.01% 6197
2024
Q4 		$195K Buy
47,462
+27,036
+132% +$147K ﹤0.01% 4545
2024
Q3 		$144K Buy
20,426
+18,017
+748% +$135K ﹤0.01% 4854
2024
Q2 		$15K Buy
2,409
+2,259
+1,506% +$15.4K ﹤0.01% 7142
2024
Q1 		$1K Buy
+150
New +$1.46K ﹤0.01% 8633
2023
Q4 		– Sell
-12,945
Closed -$109K – 9669
2023
Q3 		$108K Buy
12,945
+2,353
+22% +$25.3K ﹤0.01% 5005
2023
Q2 		$133K Buy
10,592
+2,509
+31% +$31.2K ﹤0.01% 4748
2023
Q1 		$133K Buy
8,083
+7,412
+1,105% +$133K ﹤0.01% 4828
2022
Q4 		$10K Buy
671
+410
+157% +$7.85K ﹤0.01% 7570
2022
Q3 		$5K Buy
+261
New +$5.73K ﹤0.01% 8808
2022
Q2 		– Sell
-2,710
Closed -$58.1K – 10907
2022
Q1 		$81K Buy
+2,710
New +$65.8K ﹤0.01% 6452

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Simplex Trading's RLAY Position: Q3 2025 in Review

Simplex Trading sold out of Relay Therapeutics (RLAY) in Q3 2025, closing a stake of 2,984 shares — an estimated $11.4K sold.

Simplex Trading first reported a position in RLAY in Q1 2022 and held it in 12 quarters. The position peaked at $195K in Q4 2024. 199 funds tracked by Wall St. Rank hold RLAY as of Q3 2025.

  • Simplex Trading reported no remaining Relay Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 2,984 Relay Therapeutics shares in Q3 2025, an estimated $11.4K.
  • Simplex Trading first reported a position in Relay Therapeutics in Q1 2022 and held it in 12 quarters.
  • Simplex Trading's Relay Therapeutics position peaked at $195K in Q4 2024.
  • 199 funds tracked by Wall St. Rank held Relay Therapeutics as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.